Iterum Therapeutics Plc (ITRM)
0.4694
+0.01
(+2.04%)
USD |
NASDAQ |
Dec 11, 16:00
0.4753
+0.01
(+1.26%)
After-Hours: 20:00
Iterum Therapeutics EPS Diluted (Quarterly): -0.196 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amarin Corp. Plc | -0.3702 |
| Jazz Pharmaceuticals Plc | 4.081 |
| Prothena Corp. Plc | -0.6788 |
| GH Research Plc | -0.226 |
| Mural Oncology Plc | -0.214 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -8.979M |
| Revenue (Quarterly) | 0.39M |
| Total Expenses (Quarterly) | 9.369M |
| Enterprise Value | 43.69M |
| Gross Profit Margin (Quarterly) | 3.85% |
| Profit Margin (Quarterly) | -2.30K% |
| Earnings Yield | -159.6% |
| Normalized Earnings Yield | -141.41 |